Search

Learn how a new imaging approach lights up nerves so they can be avoided during prostate cancer surgery.

… Wednesday, July 9, 2025 Men having  prostate cancer  surgery often fear  side effects  that can result from the procedure. Removing the tumor risks damage to surrounding nerves, resulting in erectile dysfunction and incontinence. Now a new way to light up nerves during the operation may help surgeons

Memorial Sloan Kettering Cancer Center (MSK) researchers published new results that found that individuals with low-risk or intermediate-risk myeloma precursor disease known as monoclonal gammopathy of undetermined significance (MGUS) can convert to high-risk MGUS and progress to multiple myeloma within a five-year window. This research clinically supports recommendations for annual blood tests for all individuals diagnosed with MGUS along with re-assessments of a patient’s clinical-risk status. Their research was published today online in JAMA Oncology.

… Thursday, July 18, 2019 Memorial Sloan Kettering Cancer Center (MSK) researchers published new results that found that individuals with low-risk or intermediate-risk myeloma precursor disease known as monoclonal gammopathy of undetermined significance (MGUS ) can convert to high-risk MGUS and progress

AACR Project GENIE steering committee head and Chair of MSK’s Human Oncology and Pathogenesis Program, Dr. Charles Sawyers, discusses how the first batch of genomic sequencing data fulfills an unmet need in oncology.

… Wednesday, February 15, 2017 In early 2017 a global collaboration of eight cancer centers led by Memorial Sloan Kettering and coordinated by the American Association for Cancer Research (AACR), released its first batch of data: genomic sequencing information on tumors from over 19,000 cancer patients

Scientists have learned that a drug activates a form of highly inflammatory programmed cell death called pyroptosis — a discovery that sheds light on immune function.

… Monday, December 19, 2016 Summary A drug called Val-boroPro triggers an immune response against cancer in mice, but until now, researchers didn’t know the mechanism. The laboratory of Daniel Bachovchin at MSK discovered that Val-boroPro blocks two proteins, DPP8 and DPP9, causing a form of inflammatory

The risk of breast cancer increases as you age. MSK has breast cancer experts with special training and experience treating older patients.

… Thursday, September 7, 2023 When Vivian Moore was diagnosed with breast cancer at age 80, she worried how well she would tolerate the treatments. Living a full life, she was active in her church and busy with sewing, knitting, and sketching. She wanted to continue doing the things she loves. While some

Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce that it is ranked among one of the top organizations with the greatest number of highly cited scientific researchers worldwide, according to the annual list of Highly Cited Researchers published by the Institute for Scientific Information at Clarivate.

… Wednesday, November 15, 2023 Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce that it is ranked among one of the top organizations with the greatest number of highly cited scientific researchers worldwide, according to the  annual list  of Highly Cited Researchers published by the 

At any given time, close to 700 teenagers and young adults are in active treatment at Memorial Sloan Kettering. On March 18, MSK opened a hip new space dubbed the Lounge as part of the newly launched Teen and Young Adult Program designed to give these young patients the support they need during a turbulent time.

… Tuesday, March 22, 2016 Summary At any given time, close to 700 teenagers and young adults are in active treatment at Memorial Sloan Kettering. On March 18, MSK opened a hip new space dubbed the Lounge as part of the newly launched Teen and Young Adult Program designed to give patients 16-28 years of

Topical minoxidil can be of significant benefit to women with breast cancer who develop alopecia during treatment with endocrine therapies, our most recent research shows.

… Wednesday, May 16, 2018 Topical minoxidil can be of significant benefit to women with breast cancer who develop alopecia during treatment with endocrine therapies, our most recent research shows. In the study, published in JAMA Dermatology , (1)) we identified alopecia with a similar pattern to the androgenetic

Meet the four young ambassadors featured in the annual Stop & Shop campaign to fundraise for the Department of Pediatrics at Memorial Sloan Kettering.

… Monday, June 11, 2018 Summary For nearly 20 years, Memorial Sloan Kettering has partnered with Stop & Shop supermarkets to raise funds for pediatric cancer research. Meet the four spunky kids representing MSK across New York, New Jersey, and Connecticut for this year’s campaign. The next time you visit

A phase 3 trial for myelofibrosis found that adding pelabresib to ruxolitinib was more effective than ruxolitinib alone and did not significantly increase side effects.

… Tuesday, April 29, 2025 An international phase 3 clinical trial of a new drug combination for treating the blood cancer  myelofibrosis found that adding a second, experimental drug to standard treatment was more effective than the standard treatment alone. Further, adding the second drug did not significantly